Bio-Rad Laboratories Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
4.2%projected annual EPS growth
Analyst Coverage
5analysts covering
FY EPS (est.)
$9.48next fiscal year
Monitoring Framework
Key Performance Indicators
Currency-Neutral Revenue Growth Quarterly-4.2%Target: -3.0% to +0.5%
Non-GAAP Operating Margin Quarterly6.6%Target: 10.0% to 12.0%
Free Cash Flow Quarterly78.1M
Watch Items
- Sartorius AG Equity Investment ValuationAction: Assess impact on GAAP net income and evaluate potential strategic options to unlock value.
- Middle East Conflict Revenue ImpactAction: Adjust manufacturing absorption strategies and reallocate commercial resources to other regions.
Research as of 19 Jun 2026